Machine learning in oncology-Perspectives in patient-reported outcome research. German version

Background Increasing data volumes in oncology pose new challenges for data analysis. Machine learning, a branch of artificial intelligence, can identify patterns even in very large and less structured datasets. Objective This article provides an overview of the possible applications for machine learning in oncology. Furthermore, the potential of machine learning in patient-reported outcome (PRO) research is discussed. Materials and methods We conducted a selective literature search (PubMed, MEDLINE, IEEE Xplore) and discuss current research. Results There are three primary applications for machine learning in oncology: (1) cancer detection or classification; (2) overall survival prediction or risk assessment; and (3) supporting therapy decision-making and prediction of treatment response. Generally, machine learning approaches in oncology PRO research are scarce and few studies integrate PRO data into machine learning models. Discussion Machine learning is a promising area of oncology, but few models have been transferred into clinical practice. The promise of personalized cancer therapy and shared decision-making through machine learning has yet to be realized. As an equally important emerging research area in oncology, PROs should also be incorporated into machine learning approaches. To gather the data necessary for this, broad implementation of PRO assessments in clinical practice, as well as the harmonization of existing datasets, is suggested.